Page last updated: 2024-11-03

psilocin and Electrocardiogram QT Prolonged

psilocin has been researched along with Electrocardiogram QT Prolonged in 1 studies

psilocin: psilocybine minus the phosphate ester; RN given refers to parent cpd; structure
psilocin : A tryptamine alkaloid that is N,N-dimethyltryptamine carrying an additional hydroxy substituent at position 4. A hallucinogenic alkaloid isolated in trace amounts from Psilocybe mushrooms (also known as Teonanacatl or "magic mushrooms").

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Dahmane, E1
Hutson, PR1
Gobburu, JVS1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 1, Two-Part Study in Healthy Volunteers to Evaluate The Effect of Psilocybin on Cardiac Repolarization and The Effect of Food on Psilocybin Pharmacokinetics[NCT05478278]Phase 160 participants (Actual)Interventional2022-06-22Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for psilocin and Electrocardiogram QT Prolonged

ArticleYear
Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin.
    Clinical pharmacology in drug development, 2021, Volume: 10, Issue:1

    Topics: Adult; Dose-Response Relationship, Drug; Electrocardiography; Female; Hallucinogens; Healthy Volunte

2021